Literature DB >> 11793427

Alpha(2A)-adrenergic receptors are present in mu-opioid receptor containing neurons in rat medial nucleus tractus solitarius.

Michael J Glass1, Virginia M Pickel.   

Abstract

Agonists of the alpha-2A-adrenergic- (alpha(2A)-AR) and the mu-opioid-receptor (muOR) jointly affect autonomic functions that are also disregulated in animals undergoing withdrawal from chronic administration of the muOR agonist morphine. Cardiovascular and gastrointestinal reflexes are mediated, in part, by the medial nucleus of the solitary tract (mNTS) at caudal (cNTS) and intermediate (iNTS) subregions. Together, this evidence suggests that alpha(2A)-AR and muOR may be colocalized within many of the same neuronal profiles in both the intermediate and caudal mNTS. In order to examine whether alpha(2A)-AR and muOR are present within common somata, dendrites, or axon terminals in the mNTS, we used electron microscopic immunocytochemistry for the detection of antisera against each receptor at intermediate and caudal levels of this brain region. Most of the dually labeled profiles were somata and dendrites. Of all dual-labeled profiles in the iNTS 49% were somata and were 47% dendrites, whereas in the cNTS 61% were somata and 32% were dendrites. Within dual-labeled profiles, the intracellular distribution of alpha(2A)-AR and muOR differed. MuOR was more frequently associated with the plasmalemma, whereas alpha(2A)-AR was often affiliated with vesicular organelles. Few axon terminals, and even fewer glia, contained both markers. We also frequently observed single-labeled alpha(2A)-AR glia that apposed exclusively muOR-containing dendrites or axon terminals. These findings indicate that somata and dendrites contain functional sites for convergent muOR and alpha(2A)-AR activation. In addition, each receptor is positioned for involvement in intercellular signaling between apposed neurons and glia. Activation of alpha(2A)-AR on muOR-containing somata or dendrites, or on glia apposed to muOR-containing neurons, may help to account for the efficacy of alpha(2A)-AR agonists in relieving some of the autonomic symptoms of opiate withdrawal. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11793427     DOI: 10.1002/syn.10036

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  9 in total

Review 1.  Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.

Authors:  Mark R Hutchinson; Yehuda Shavit; Peter M Grace; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  Pharmacol Rev       Date:  2011-07-13       Impact factor: 25.468

2.  GPCR dimerization in brainstem nuclei contributes to the development of hypertension.

Authors:  Gwo-Ching Sun; Wen-Yu Ho; Bo-Rung Chen; Pei-Wen Cheng; Wen-Han Cheng; Mei-Chi Hsu; Tung-Chen Yeh; Michael Hsiao; Pei-Jung Lu; Ching-Jiunn Tseng
Journal:  Br J Pharmacol       Date:  2015-03-17       Impact factor: 8.739

Review 3.  Heteromerization of G protein-coupled receptors: relevance to neurological disorders and neurotherapeutics.

Authors:  Laura Albizu; José L Moreno; Javier González-Maeso; Stuart C Sealfon
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-11       Impact factor: 4.388

4.  Ultrastructural relationship between N-methyl-D-aspartate-NR1 receptor subunit and mu-opioid receptor in the mouse central nucleus of the amygdala.

Authors:  M J Glass; L Vanyo; L Quimson; V M Pickel
Journal:  Neuroscience       Date:  2009-07-14       Impact factor: 3.590

5.  Functional characterization of G-protein-coupled receptors: a bioinformatics approach.

Authors:  L Tovo-Rodrigues; A Roux; M H Hutz; L A Rohde; A S Woods
Journal:  Neuroscience       Date:  2014-07-02       Impact factor: 3.590

Review 6.  TNFalpha: a trigger of autonomic dysfunction.

Authors:  Gerlinda E Hermann; Richard C Rogers
Journal:  Neuroscientist       Date:  2007-10-02       Impact factor: 7.519

7.  The relationship between resting blood pressure and acute pain sensitivity: effects of chronic pain and alpha-2 adrenergic blockade.

Authors:  Stephen Bruehl; Ok Y Chung; Laura Diedrich; André Diedrich; David Robertson
Journal:  J Behav Med       Date:  2007-10-17

8.  Dexmedetomidine infusion to facilitate opioid detoxification and withdrawal in a patient with chronic opioid abuse.

Authors:  Surjya Prasad Upadhyay; Piyush Narayan Mallick; Waleed Mohamed Elmatite; Manish Jagia; Salah Taqi
Journal:  Indian J Palliat Care       Date:  2011-09

9.  Adrenergic Agonists Bind to Adrenergic-Receptor-Like Regions of the Mu Opioid Receptor, Enhancing Morphine and Methionine-Enkephalin Binding: A New Approach to "Biased Opioids"?

Authors:  Robert Root-Bernstein; Miah Turke; Udaya K Tiruttani Subhramanyam; Beth Churchill; Joerg Labahn
Journal:  Int J Mol Sci       Date:  2018-01-17       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.